Kyowa Kirin: High-Risk High-Return Call Reiterating Our Buy Rating [Seeking Alpha]
MEI Pharma, Inc. (MEIP)
Last mei pharma, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.meipharma.com
Company Research
Source: Seeking Alpha
The company's recent track record for new drug trial success has been poor, but the partnership with Amgen provides reassurance. Kyowa Kirin is well-capitalized with a strong balance sheet and free cash flow, making the shares attractive on current consensus forecasts. Investment thesis We view Kyowa Kirin ( OTCPK:KYKOF ) shares as being a cheap option on the positive outcome for the atopic dermatitis (eczema) drug currently being developed in partnership with Amgen ( AMGN ). Despite being 40% down from our initial rating, we are reiterating our buy rating. Quick primer Kyowa Kirin is a Japanese pharmaceutical company created by the merger of Kyowa Hakko and Kirin Pharma in 2008. Known for its antibody-based treatments, the current key earnings driver is its proprietary rickets treatment Crysvita collaborating with Ultragenyx ( RARE ). In June 2021, the company announced that it will jointly develop and commercialize its in-house atopic dermatitis (eczema) drug KHK4083 with
Show less
Read more
Impact Snapshot
Event Time:
MEIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MEIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MEIP alerts
High impacting MEI Pharma, Inc. news events
Weekly update
A roundup of the hottest topics